Merit Medical to Present 6-Month Outcomes from Randomized Arm of WRAPSODY™ Arteriovenous Access Efficacy (WAVE) Pivotal Study at Two Upcoming Medical Meetings
August 01, 2024 16:05 ET
|
Merit Medical Systems, Inc.
SOUTH JORDAN, Utah, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced plans to release findings from its WAVE...
Fidus Investment Corporation Announces Second Quarter 2024 Financial Results
August 01, 2024 16:05 ET
|
Fidus Investment Corporation
Board of Directors Declared Total Dividends of $0.57 per Share for Third Quarter 2024 Base Dividend of $0.43 and Supplemental Dividend of $0.14 Per Share EVANSTON, Ill., Aug. 01, 2024 ...
Altair Announces Second Quarter 2024 Financial Results
August 01, 2024 16:05 ET
|
Altair Engineering Inc.
TROY, Mich., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Altair (Nasdaq: ALTR), a global leader in computational intelligence, today released its financial results for the second quarter and six months ended...
Sportsman’s Warehouse Secures $45 Million Term Loan to Strengthen its Balance Sheet and Enhance Liquidity
August 01, 2024 16:05 ET
|
Sportsman's Warehouse Holdings, Inc.
WEST JORDAN, Utah, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Sportsman’s Warehouse Holdings, Inc. (“Sportsman’s Warehouse” or the “Company”) (Nasdaq: SPWH) announced today that it has secured a $45 million...
Myriad Genetics Advances International Reorganization and Completes Sale of EndoPredict Business to Eurobio Scientific
August 01, 2024 16:05 ET
|
Myriad Genetics, Inc.
SALT LAKE CITY, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced it completed the sale of its EndoPredict®...
Cardiff Oncology to Report Second Quarter 2024 Results and Provide Business Update
August 01, 2024 16:05 ET
|
Cardiff Oncology, Inc.
SAN DIEGO, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of...
OPKO Health to Report Second Quarter 2024 Financial Results on August 7, 2024
August 01, 2024 16:05 ET
|
OPKO Health, Inc.
MIAMI, Aug. 01, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three and six months ended June 30, 2024 after the close of the U.S....
Oxbridge Re Announces 2024 Second Quarter Results on August 8, 2024
August 01, 2024 16:05 ET
|
Oxbridge Re Holdings Limited
GRAND CAYMAN, Cayman Islands, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Oxbridge Re (NASDAQ: OXBR) announced that it plans to hold a conference call on Thursday August 8, 2024 at 4:30 p.m. Eastern time to...
Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)
August 01, 2024 16:05 ET
|
Terns Pharmaceuticals, Inc.
FOSTER CITY, Calif., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of...
iRhythm Technologies Announces Second Quarter 2024 Financial Results
August 01, 2024 16:05 ET
|
iRhythm
SAN FRANCISCO, Aug. 01, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and...